Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

I’m 57 with a $1.5M home and a $400K rental with a 7.4% mortgage. I’m getting a $375K check soon. My financial adviser told ...

This was the stock's second consecutive day of losses.

Furthermore, Humana continues to face pressure from rising medical costs, and its benefits expense ratio increased by 270 bps y-o-y to 89%, weighing on its stock performance. Our detailed analysis ...

Humana Inc.’s stock was up 2% Friday after three straight sessions of declines, but investors paying attention to the performance of its bonds on Thursday may have had something of a heads-up on ...

Humana (NYSE:HUM ... by a significant 13% over the last month. Given that stock prices are usually aligned with a company's financial performance in the long-term, we decided to study its ...

Sarah James, a stock analyst with Cantor Fitzgerald ... The lower rating won’t affect Humana’s performance until 2026, but the company said it was “disappointed with its performance and ...

Shares of Humana (HUM) are plummeting after the company ... and discuss how the rating is weighing on the health insurer's stock performance. For more expert insight and the latest market action ...

Humana (NYSE: HUM) currently trades around ... It compares these trends to the stock’s performance during the 2008 recession. In contrast, here’s how HUM stock and the broader market performed ...

Humana stock closed at $246.49 ... The company said it also is focused on improving its performance to regain its star rating. Humana, one of the biggest providers of Medicare Advantage coverage ...

Shares of Humana Inc. rallied 3.94% to $247.34 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.09% to 5,963.60 and the Dow ...